A longtime executive of Siemens, Reitermann has held positions as vice president of sales, marketing and innovation of the Siemens Angiography and X-ray Division, partner of Siemens Management Consulting, and project manager at the corporate strategies division of Siemens Corporate Planning and Development. Reitermann received training at Hans-Grueninger-Gymnasium in Markgroeningen, Germany, completed his graduate degree in industrial engineering from the University of Karlsruhe, Germany, and finished his master's of business administration from the University of British Columbia, Canada.

Reitermann will turn the role of CEO of Siemens Molecular Imaging Business Unit over to Britta Fuenfstueck, who will take responsibility for setting Siemens' molecular imaging objectives and financial planning. Meanwhile, Reitermann's predecessor, Heinrich Kolem, will take on a new challenge, assuming the role of global head of Siemens Healthcare's Angiography, Fluoroscopy and X-ray business unit.


Siemens Healthcare is a leading supplier of diagnostic, therapeutic and informatics technologies. The company employs about 49,000 people in 130 countries around the world.

Back to HCB News

More Voices